GoodRx Holdings (GDRX) Goodwill (2019 - 2026)

GoodRx Holdings has disclosed Goodwill across 8 years of filings, most recently posting $430.3 million for Q1 2026.

• Goodwill for Q1 2026 came in at $430.3 million, up 2.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $430.3 million (up 2.04% YoY), and the FY2025 annual result was $430.3 million, up 4.76% from the prior year.
• Goodwill came in at $430.3 million for Q1 2026 at GoodRx Holdings, roughly flat from $430.3 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $430.3 million in Q4 2025 to a low of $334.6 million in Q1 2022.
• The 5-year median for Goodwill is $412.1 million (2022), against an average of $411.4 million.
• Across the five-year window, Goodwill climbed 29.69% in 2022 and slipped 0.76% in 2023, its largest moves.
• GoodRx Holdings' Goodwill stood at $412.1 million in 2022, then slipped by 0.33% to $410.8 million in 2023, then changed by 0.0% to $410.8 million in 2024, then climbed by 4.76% to $430.3 million in 2025, then changed by 0.0% to $430.3 million in 2026.
• The last three Goodwill figures came in at $430.3 million (Q1 2026), $430.3 million (Q4 2025), and $421.7 million (Q3 2025), per Business Quant data.